Mimetas Contract - Development of 3D Human Blood Brain Barrier Formation Assay (
Past New Requirement Updated
- Agency
-
Food and Drug Administration
Department of Health and Human Services
- Solicitation expected
- Estimated value
- $25,000 to $250,000
- Set-aside
- No set-aside
Forecast facts
- Anticipated award
- NAICS code
- 541990 All Other Professional, Scientific, and Technical Services
- Points of contact
-
- HFP Acquisition Liaison hfpacquisitions@fda.hhs.gov
Forecast details come from HHS's procurement forecast. Agencies' dates and values are estimates.
About this forecast
The Food and Drug Administration is seeking external contract research support to develop a new three-dimensional human blood-brain barrier formation assay, which aligns with the HFP priority research area of developmental neurotoxicity. This new requirement contract will involve the design and development of an advanced assay system to support FDA's research objectives in understanding neurotoxic effects during developmental stages. The solicitation is estimated to be released on May 1, 2026, with an anticipated contract award date of September 1, 2026.
The estimated award value for this contract ranges from $25,000 to $250,000, providing flexibility based on the scope and approach proposed by contractors. Interested parties should contact the FDA's Acquisition Liaison at hfpacquisitions@fda.hhs.gov for additional information and clarification regarding requirements. This contract falls under NAICS code 541990 (All Other Professional, Scientific, and Technical Services) and represents a competitive opportunity without any set-aside restrictions.
Forecast text
External contract research support to develop a new assay in the HFP priority research area of developmental neurotoxicity
On GovTribe
Work this forecast
- Track it in your pipeline
- Find teaming partners
- Similar forecasts
- Ask GovTribe AI about this forecast